Citations for
1EPCAM
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
Fong D, Seeber A, Terracciano L, Kasal A, Mazzoleni G, Lehne F, Gastl G, Spizzo G.
J Clin Pathol 67(5):408-14. doi: 10.1136/jclinpath-2013-201932. Epub 2014 Jan 24. 2014
2DIAR5, EPCAM
Tufting enteropathy revisited: the utility of MOC31 (EpCAM) immunohistochemistry in diagnosis.
Ranganathan S, Schmitt LA, Sindhi R.
Am J Surg Pathol 38(2):265-72. doi: 10.1097/PAS.0000000000000106. 2014
3EPCAM, ERAP2
EpCAM associates with endoplasmic reticulum aminopeptidase 2 (ERAP2) in breast cancer cells.
Gadalla SE, Öjemalm K, Vasquez PL, Nilsson I, Ericsson C, Zhao J, Nistér M.
Biochem Biophys Res Commun 439(2):203-8. doi: 10.1016/j.bbrc.2013.08.059. Epub 2013 Aug 26. 2013
4EPCAM
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
Martowicz A, Rainer J, Lelong J, Spizzo G, Gastl G, Untergasser G.
Mol Cancer 12:56. doi: 10.1186/1476-4598-12-56. 2013
5CLDN7, EPCAM
Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.
Wu CJ, Mannan P, Lu M, Udey MC.
J Biol Chem 288(17):12253-68. doi: 10.1074/jbc.M113.457499. Epub 2013 Mar 13. 2013
6DIAR5, EPCAM
Absence of cell-surface EpCAM in congenital tufting enteropathy.
Schnell U, Kuipers J, Mueller JL, Veenstra-Algra A, Sivagnanam M, Giepmans BN.
Hum Mol Genet 22(13):2566-71. doi: 10.1093/hmg/ddt105. Epub 2013 Mar 5. 2013
7EPCAM
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
Chaves-Pérez A, Mack B, Maetzel D, Kremling H, Eggert C, Harréus U, Gires O.
Oncogene 32(5):641-50. doi: 10.1038/onc.2012.75. Epub 2012 Mar 5. 2013
8EPCAM, MMP7
MMP7 is a target of the tumour-associated antigen EpCAM.
Denzel S, Mack B, Eggert C, Massoner P, Stöcklein N, Kemming D, Harréus U, Gires O.
Int J Exp Pathol 93(5):341-53. doi: 10.1111/j.1365-2613.2012.00826.x. 2012
9EPCAM
EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.
Lei Z, Maeda T, Tamura A, Nakamura T, Yamazaki Y, Shiratori H, Yashiro K, Tsukita S, Hamada H.
Dev Biol 371(2):136-45. doi: 10.1016/j.ydbio.2012.07.005. Epub 2012 Jul 20. 2012
10EPCAM
Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo.
Gaiser MR, Lämmermann T, Feng X, Igyarto BZ, Kaplan DH, Tessarollo L, Germain RN, Udey MC.
Proc Natl Acad Sci U S A 109(15):E889-97. doi: 10.1073/pnas.1117674109. Epub 2012 Mar 12. 2012
11EPCAM, HNPCC1
Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ.
Hum Mutat 32(4):407-14. doi: 10.1002/humu.21446. Epub 2011 Mar 1. 2011
12EPCAM
Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Takahashi H, Ohigashi H, Tomita Y, Ishikawa O, Mori M, Doki Y.
Oncogene 30(31):3468-76. doi: 10.1038/onc.2011.59. Epub 2011 Mar 14. 2011
13CLDN7, EPCAM
Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF, Ho HN, Kuo HC.
J Biol Chem 286(38):33520-32. Epub 2011 Jul 28. 2011
14EPCAM
The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling.
Maghzal N, Vogt E, Reintsch W, Fraser JS, Fagotto F.
J Cell Biol 191(3):645-59. doi: 10.1083/jcb.201004074. Epub 2010 Oct 25. 2010
15EPCAM, HNPCC1
Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E.
Hum Mutat 30(2):197-203. 2009
16EPCAM, HNPCC
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N.
Nat Genet 41(1):112-7. Epub 2008 Dec 21. 2009
17DIAR5, EPCAM
Tufting enteropathy and chronic arthritis: a newly recognized association with a novel EpCAM gene mutation.
Al-Mayouf SM, Alswaied N, Alkuraya FS, Almehaidib A, Faqih M.
J Pediatr Gastroenterol Nutr 49(5):642-4. No abstract available. PMID: 19820410 2009
18EPCAM
The emerging role of EpCAM in cancer and stem cell signaling.
Munz M, Baeuerle PA, Gires O.
Cancer Res 69(14):5627-9. Epub 2009 Jul 7. Review.PMID: 19584271 2009
19EPCAM, MLH1
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H, Kleibeuker JH, Sijmons RH.
Genes Chromosomes Cancer 48(8):737-44.PMID: 19455606 2009
20EPCAM
EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer.
Wenqi D, Li W, Shanshan C, Bei C, Yafei Z, Feihu B, Jie L, Daiming F.
J Cancer Res Clin Oncol 135(9):1277-85. Epub 2009 Mar 18.PMID: 19294417 2009
21DIAR5, EPCAM
Identification of EpCAM as the gene for congenital tufting enteropathy.
Sivagnanam M, Mueller JL, Lee H, Chen Z, Nelson SF, Turner D, Zlotkin SH, Pencharz PB, Ngan BY, Libiger O, Schork NJ, Lavine JE, Taylor S, Newbury RO, Kolodner RD, Hoffman HM.
Gastroenterology 135(2):429-37. Epub 2008 May 15.PMID: 18572020 [PubMed 2008
22EPCAM
Prognostic significance of EpCAM expression in human esophageal cancer.
Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Kuwano H.
Int J Oncol 30(1):171-9. 2007
23EPCAM, GDLD, TACSTD2
Phenotypic investigation of cell junction-related proteins in gelatinous drop-like corneal dystrophy.
Takaoka M, Nakamura T, Ban Y, Kinoshita S.
Invest Ophthalmol Vis Sci 48(3):1095-101. 2007
24EPCAM
The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zoller M.
Exp Cell Res 309(2):345-57. 2005
25EPCAM
EpCAM expression in retinoblastoma: a novel molecular target for therapy.
Krishnakumar S, Mohan A, Mallikarjuna K, Venkatesan N, Biswas J, Shanmugam MP, Ren-Heidenreich L.
Invest Ophthalmol Vis Sci 45(12):4247-50. 2004
26EPCAM
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O.
Oncogene 23(34):5748-58. 2004
27EPCAM
Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter.
Gires O, Eskofier S, Lang S, Zeidler R, Munz M.
Anticancer Res 23(4):3255-61. 2003
28EPCAM, TACSTD2
Retroposition in a family of carcinoma-associated antigen genes.
Linnenbach AJ, et al.
Mol Cell Biol 13 : 1507-1515. 1993
29EPCAM
Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.
Szala S, et al.
Proc Natl Acad Sci U S A 87 : 3542-3546. 1990
30EPCAM, TACSTD2
Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733.
Linnenbach AJ, et al.
Proc Natl Acad Sci U S A 86(1):27-31. 1989
31EPCAM
Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antiboby AUAI.
Spurr NK, et al.
Int J Cancer 38 : 631-636. 1986